Long-Term Safety and Efficacy of Repeated Cycles of RimabotulinumtoxinB in the Treatment of Chronic Sialorrhea: Results of the OPTIMYST Trial by Rajesh Pahwa, Eric Molho, Mark Lew, Khashayar Dashtipour, Ramon A. Gil, Fredy J. Revilla, Thomas Clinch, Peibing Qin, Stuart H. Isaacson, on behalf of the OPen Label Trial of Intraglandular MYobloc injections for Sialorrhea Treatment (OPTIMYST) study group

Get full text